Stock DNA
Pharmaceuticals & Biotechnology
HKD 6,362 Million ()
NA (Loss Making)
NA
0.00%
-0.56
-999,999.00%
3.36
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Jun 2015)
Net Profit:
-3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-21.82%
0%
-21.82%
6 Months
-20.15%
0%
-20.15%
1 Year
10.22%
0%
10.22%
2 Years
-12.98%
0%
-12.98%
3 Years
-47.96%
0%
-47.96%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
MicroPort NeuroTech Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
53.82%
EBIT Growth (5y)
-189.60%
EBIT to Interest (avg)
-5.56
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.59
Sales to Capital Employed (avg)
0.00
Tax Ratio
1.59%
Dividend Payout Ratio
39.92%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.14
EV to EBIT
-761.64
EV to EBITDA
-854.92
EV to Capital Employed
8.71
EV to Sales
835.33
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1.14%
ROE (Latest)
-0.77%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'15 - YoY
Jun'15
Jun'14
Change(%)
Net Sales
2.20
0.80
175.00%
Operating Profit (PBDIT) excl Other Income
-0.10
-1.90
94.74%
Interest
0.60
0.80
-25.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.90
-2.10
-38.10%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2015 is 175.00% vs 300.00% in Jun 2014
Consolidated Net Profit
YoY Growth in quarter ended Jun 2015 is -38.10% vs 32.26% in Jun 2014
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
735.50
636.50
15.55%
Operating Profit (PBDIT) excl Other Income
277.70
200.00
38.85%
Interest
4.10
115.60
-96.45%
Exceptional Items
-27.20
-24.70
-10.12%
Consolidate Net Profit
148.70
-28.70
618.12%
Operating Profit Margin (Excl OI)
270.10%
210.60%
5.95%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 15.55% vs 37.95% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 618.12% vs -198.63% in Dec 2022
About MicroPort NeuroTech Ltd. 
MicroPort NeuroTech Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






